SG11201704590RA - Pharmaceutical composition comprising bicyclic nitrogen-containing aromatic heterocyclic amide compound as active ingredient - Google Patents

Pharmaceutical composition comprising bicyclic nitrogen-containing aromatic heterocyclic amide compound as active ingredient

Info

Publication number
SG11201704590RA
SG11201704590RA SG11201704590RA SG11201704590RA SG11201704590RA SG 11201704590R A SG11201704590R A SG 11201704590RA SG 11201704590R A SG11201704590R A SG 11201704590RA SG 11201704590R A SG11201704590R A SG 11201704590RA SG 11201704590R A SG11201704590R A SG 11201704590RA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
active ingredient
aromatic heterocyclic
amide compound
containing aromatic
Prior art date
Application number
SG11201704590RA
Other languages
English (en)
Inventor
Takeyuki Nagashima
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of SG11201704590RA publication Critical patent/SG11201704590RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201704590RA 2014-12-09 2015-12-08 Pharmaceutical composition comprising bicyclic nitrogen-containing aromatic heterocyclic amide compound as active ingredient SG11201704590RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014249348 2014-12-09
PCT/JP2015/084340 WO2016093202A1 (ja) 2014-12-09 2015-12-08 二環式含窒素芳香族ヘテロ環アミド化合物を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
SG11201704590RA true SG11201704590RA (en) 2017-07-28

Family

ID=56107385

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704590RA SG11201704590RA (en) 2014-12-09 2015-12-08 Pharmaceutical composition comprising bicyclic nitrogen-containing aromatic heterocyclic amide compound as active ingredient

Country Status (15)

Country Link
US (1) US20170360779A1 (zh)
EP (1) EP3231424A1 (zh)
JP (1) JPWO2016093202A1 (zh)
KR (1) KR20170088881A (zh)
CN (1) CN107106557A (zh)
AU (1) AU2015362515A1 (zh)
BR (1) BR112017012376A2 (zh)
CA (1) CA2970226A1 (zh)
IL (1) IL252664A0 (zh)
MA (1) MA41157A (zh)
MX (1) MX2017007640A (zh)
RU (1) RU2017120189A (zh)
SG (1) SG11201704590RA (zh)
TW (1) TW201634050A (zh)
WO (1) WO2016093202A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020008A1 (en) * 2000-09-06 2002-03-14 The Scripps Research Institute Inhibitors of nadh:ubiquinone oxidoreductase
WO2014199933A1 (ja) * 2013-06-10 2014-12-18 アステラス製薬株式会社 二環式含窒素芳香族ヘテロ環アミド化合物

Also Published As

Publication number Publication date
MA41157A (fr) 2017-10-17
IL252664A0 (en) 2017-08-31
RU2017120189A (ru) 2019-01-11
MX2017007640A (es) 2017-09-11
AU2015362515A1 (en) 2017-06-29
BR112017012376A2 (pt) 2018-04-24
TW201634050A (zh) 2016-10-01
KR20170088881A (ko) 2017-08-02
CN107106557A (zh) 2017-08-29
CA2970226A1 (en) 2016-06-16
US20170360779A1 (en) 2017-12-21
JPWO2016093202A1 (ja) 2017-09-14
WO2016093202A1 (ja) 2016-06-16
EP3231424A1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
IL281863A (en) Preparations containing meloxicam
PT3565550T (pt) Composições farmacêuticas compreendendo meloxicam e rizatriptano
IL247062A0 (en) Heterocyclic compounds, their preparation and pharmaceutical preparations containing them
IL253538B (en) Heterocyclic compound and pharmaceutical compound containing it
ZA201605379B (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
IL304109A (en) Pharmaceutical preparations containing spinamide
HK1255313A1 (zh) 含有培美曲塞或其藥學上可接受的鹽的穩定藥物組合物
HK1243927A1 (zh) 含有茶皂醇衍生物作爲活性成分的組合物
IL249010A0 (en) A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient
HK1243650A1 (zh) 包含美洛昔康的藥物組合物
IL252663A0 (en) A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient
IL252664A0 (en) A pharmaceutical preparation containing an aromatic heterocyclic amide compound containing nitrogen as an active ingredient
PT3424500T (pt) Composição farmacêutica que compreende famitinib
HK1244703A1 (zh) 一種含有咪唑啉類衍生物的藥物組合物
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
HUE058886T2 (hu) Safinamidot tartalmazó gyógyászati készítmények
HRP20220610T8 (hr) Farmaceutski pripravci koji sadrže meloksikam